trial
as of 2026-07-01Lurasidone Non-Interventional Study in Schizophrenia Patients
NCTId NCT06527885
at a glance
Phase — · Completed
Enrollment 61 (actual)
Sponsored by Aziende Chimiche Riunite Angelini Francesco S.p.A
Primary completion 2023-09-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
61 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2022-10-21
Primary completion
2023-09-12
Eligibility
ALL · 18 Years · 99 Years
Interventions & indications
Drugs
Indications
Sponsors
Hippocrates ResearchCollaborator
Sites
3 total
Brescia, ItalyGenzano di Roma, ItalySiena, Italy
Facts & assertions
4 sourced
Enrollment
61
Phase
NA
Primary Completion Date
2023-09-12
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
company
indication
indication
indication